First patient exceeding 5-year complete remission after <sup>225</sup>Ac-PSMA-TAT.

Rathke, Hendrik; Bruchertseifer, Frank; Kratochwil, Clemens; Keller, Hanno; Giesel, Frederik L; Apostolidis, Christos; Haberkorn, Uwe; Morgenstern, Alfred

First patient exceeding 5-year complete remission after ²²⁵Ac-PSMA-TAT.

Rathke, Hendrik; Bruchertseifer, Frank; Kratochwil, Clemens; Keller, Hanno; Giesel, Frederik L; Apostolidis, Christos; Haberkorn, Uwe; Morgenstern, Alfred.

Afiliación

Rathke H; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany. hendrik.rathke@med.uni-heidelberg.de.
Bruchertseifer F; European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.
Kratochwil C; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
Keller H; Urology Center Mannheim, Mannheim, Germany.
Giesel FL; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
Apostolidis C; Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Haberkorn U; European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.
Morgenstern A; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.

Eur J Nucl Med Mol Imaging ; 48(1): 311-312, 2021 01.

Article en En | MEDLINE | ID: mdl-32468252

Asunto(s)

Actinio; Compuestos Heterocíclicos con 1 Anillo; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Actinio / Compuestos Heterocíclicos con 1 Anillo Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google